High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 14,400
+100 (0.70%)
At close: Jun 11, 2026
High Tech Pharm Market Cap
High Tech Pharm has a market cap or net worth of 148.76 billion as of June 12, 2026. Its market cap has increased by 19.98% in one year.
Market Cap
148.76B
Enterprise Value
140.31B
Revenue
69.05B
Ranking
n/a
PE Ratio
16.48
Stock Price
14,400.00
Market Cap Chart
Since July 28, 2010, High Tech Pharm's market cap has increased from 96.60B to 148.76B, an increase of 53.99%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 148.76B | 16.39% |
| Dec 30, 2025 | 127.81B | -14.14% |
| Dec 30, 2024 | 148.86B | 50.05% |
| Dec 28, 2023 | 99.21B | 28.39% |
| Dec 29, 2022 | 77.27B | -20.44% |
| Dec 30, 2021 | 97.12B | -25.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 236.15B |
| CellBion | 229.58B |
| DAE HWA Pharmaceutical | 187.78B |
| GC WellBeing | 142.57B |
| Cosmax Nbt | 141.83B |
| Kyung Dong Pharmaceutical | 137.40B |
| PHARMARESEARCH BIO | 135.04B |
| Ahn-Gook Pharmaceutical | 125.93B |